At a glance
- Originator Eisai Co Ltd
- Class Antidepressants
- Mechanism of Action Monoamine oxidase A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 24 Aug 2001 No-Development-Reported for Depression in Japan (Unknown route)
- 31 Dec 1996 Preclinical development for Depression in Japan (Unknown route)